Monthly Archives: July 2015

Teva to Acquire Allergan’s Generic Business

Posted on July 31, 2015 by Mathew Lombard

Teva Pharmaceuticals is buying Allergan’s generic drug business for $40.5 billion. The Israeli pharmaceutical signed an agreement on 27 July for Allergan Generics and withdrew its plans to acquire Mylan’s business. Under the new agreement, Teva will pay Allergan $33.75 … Continue reading →

Posted in Pharmaceuticals | Leave a comment

Allergan to Acquire Oculeve

Posted on July 7, 2015 by Mathew Lombard

Dublin, Ireland-based Allergan announced it will acquire San Francisco-based Oculeve for a $125 million upfront payment plus milestone payments related to Oculeve’s lead development program OD-01, a device to treat dry eye disease. The agreement also includes the acquisition of … Continue reading →